This post from David Suhy on Twitter kind of implies the research is old which lends support to the idea that this was an FDA requirement that has just surfaced.
Dr Suhy
paper published online today w/ myself and some old colleagues at Pfizer from our past collaboration shows the diversity of shRNA from TT034